250 related articles for article (PubMed ID: 22579784)
1. Structural and functional deviations in disease-associated p97 mutants.
Tang WK; Xia D
J Struct Biol; 2012 Aug; 179(2):83-92. PubMed ID: 22579784
[TBL] [Abstract][Full Text] [Related]
2. A unique IBMPFD-related P97/VCP mutation with differential binding pattern and subcellular localization.
Erzurumlu Y; Kose FA; Gozen O; Gozuacik D; Toth EA; Ballar P
Int J Biochem Cell Biol; 2013 Apr; 45(4):773-82. PubMed ID: 23333620
[TBL] [Abstract][Full Text] [Related]
3. Imbalances in p97 co-factor interactions in human proteinopathy.
Fernández-Sáiz V; Buchberger A
EMBO Rep; 2010 Jun; 11(6):479-85. PubMed ID: 20414249
[TBL] [Abstract][Full Text] [Related]
4. IBMPFD Disease-Causing Mutant VCP/p97 Proteins Are Targets of Autophagic-Lysosomal Degradation.
Bayraktar O; Oral O; Kocaturk NM; Akkoc Y; Eberhart K; Kosar A; Gozuacik D
PLoS One; 2016; 11(10):e0164864. PubMed ID: 27768726
[TBL] [Abstract][Full Text] [Related]
5. Nucleocytoplasmic shuttling of valosin-containing protein (VCP/p97) regulated by its N domain and C-terminal region.
Song C; Wang Q; Song C; Lockett SJ; Colburn NH; Li CC; Wang JM; Rogers TJ
Biochim Biophys Acta; 2015 Jan; 1853(1):222-32. PubMed ID: 25447673
[TBL] [Abstract][Full Text] [Related]
6. Structural and Functional Analysis of Disease-Linked p97 ATPase Mutant Complexes.
Nandi P; Li S; Columbres RCA; Wang F; Williams DR; Poh YP; Chou TF; Chiu PL
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360842
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.
Custer SK; Neumann M; Lu H; Wright AC; Taylor JP
Hum Mol Genet; 2010 May; 19(9):1741-55. PubMed ID: 20147319
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin- and ATP-dependent unfoldase activity of P97/VCP•NPLOC4•UFD1L is enhanced by a mutation that causes multisystem proteinopathy.
Blythe EE; Olson KC; Chau V; Deshaies RJ
Proc Natl Acad Sci U S A; 2017 May; 114(22):E4380-E4388. PubMed ID: 28512218
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic variability in three families with valosin-containing protein mutation.
Spina S; Van Laar AD; Murrell JR; Hamilton RL; Kofler JK; Epperson F; Farlow MR; Lopez OL; Quinlan J; DeKosky ST; Ghetti B
Eur J Neurol; 2013 Feb; 20(2):251-8. PubMed ID: 22900631
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model.
Chang YC; Hung WT; Chang YC; Chang HC; Wu CL; Chiang AS; Jackson GR; Sang TK
PLoS Genet; 2011 Feb; 7(2):e1001288. PubMed ID: 21304887
[TBL] [Abstract][Full Text] [Related]
11. Valosin-containing protein (VCP) is a novel IQ motif-containing GTPase activating protein 1 (IQGAP1)-interacting protein.
Itoh N; Nagai T; Watanabe T; Taki K; Nabeshima T; Kaibuchi K; Yamada K
Biochem Biophys Res Commun; 2017 Dec; 493(4):1384-1389. PubMed ID: 28970065
[TBL] [Abstract][Full Text] [Related]
12. A novel ATP-dependent conformation in p97 N-D1 fragment revealed by crystal structures of disease-related mutants.
Tang WK; Li D; Li CC; Esser L; Dai R; Guo L; Xia D
EMBO J; 2010 Jul; 29(13):2217-29. PubMed ID: 20512113
[TBL] [Abstract][Full Text] [Related]
13. Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy.
Ju JS; Weihl CC
Hum Mol Genet; 2010 Apr; 19(R1):R38-45. PubMed ID: 20410287
[TBL] [Abstract][Full Text] [Related]
14. Different dynamic movements of wild-type and pathogenic VCPs and their cofactors to damaged mitochondria in a Parkin-mediated mitochondrial quality control system.
Kimura Y; Fukushi J; Hori S; Matsuda N; Okatsu K; Kakiyama Y; Kawawaki J; Kakizuka A; Tanaka K
Genes Cells; 2013 Dec; 18(12):1131-43. PubMed ID: 24215292
[TBL] [Abstract][Full Text] [Related]
15. The heterozygous R155C VCP mutation: Toxic in humans! Harmless in mice?
Clemen CS; Winter L; Strucksberg KH; Berwanger C; Türk M; Kornblum C; Florin A; Aguilar-Pimentel JA; Amarie OV; Becker L; Garrett L; Hans W; Moreth K; Neff F; Pingen L; Rathkolb B; Rácz I; Rozman J; Treise I; Fuchs H; Gailus-Durner V; de Angelis MH; Vorgerd M; Eichinger L; Schröder R
Biochem Biophys Res Commun; 2018 Sep; 503(4):2770-2777. PubMed ID: 30100055
[TBL] [Abstract][Full Text] [Related]
16. Neuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice.
Rodriguez-Ortiz CJ; Hoshino H; Cheng D; Liu-Yescevitz L; Blurton-Jones M; Wolozin B; LaFerla FM; Kitazawa M
Am J Pathol; 2013 Aug; 183(2):504-15. PubMed ID: 23747512
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of a drosophila IBMPFD model reveals potential pathogenic mechanisms.
Chan HT; Lee TR; Huang SH; Lee HY; Sang TK; Chan HL; Lyu PC
Mol Biosyst; 2012 Jun; 8(6):1730-41. PubMed ID: 22481368
[TBL] [Abstract][Full Text] [Related]
18. The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97/VCP.
Niwa H; Ewens CA; Tsang C; Yeung HO; Zhang X; Freemont PS
J Biol Chem; 2012 Mar; 287(11):8561-70. PubMed ID: 22270372
[TBL] [Abstract][Full Text] [Related]
19. The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis.
Nalbandian A; Donkervoort S; Dec E; Badadani M; Katheria V; Rana P; Nguyen C; Mukherjee J; Caiozzo V; Martin B; Watts GD; Vesa J; Smith C; Kimonis VE
J Mol Neurosci; 2011 Nov; 45(3):522-31. PubMed ID: 21892620
[TBL] [Abstract][Full Text] [Related]
20. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
Weihl CC; Dalal S; Pestronk A; Hanson PI
Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
